Albuterol 0.833 mg/ML / ipratropium bromide 0.167 mg/ML [DuoNeb]
RxNorm 1437703

Concept Hierarchy & Relationship Mapping

RxNorm Concept Unique Identifier (RxCUI) 1437703 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: albuterol 0.833 mg/ML / ipratropium bromide 0.167 mg/ML [DuoNeb].

The following semantic concepts and normalized strings are associated with this clinical entity:

SBDC
Albuterol 0.833 mg/ML / ipratropium bromide 0.167 mg/ML [DuoNeb]
AUI:12303353
View

This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.

SBDC

Semantic Branded Drug Component (SBDC):
Albuterol 0.833 mg/ML / ipratropium bromide 0.167 mg/ML [DuoNeb]
(Atom ID: 12303353)

Clinical Status & Identity

Prescribable Status
NO (Reference)
Part of the RxNorm Current Prescribable Content subset including all drugs available for prescription in the USA.
Concept Description
albuterol 0.833 MG/ML / ipratropium bromide 0.167 MG/ML [DuoNeb]
Official description of the drug concept as defined in the source vocabulary.
Suppress Flag
O
N: Not suppressible | O: Obsolete | Y: Suppressed by editor | E: Unquantified non-prescribable drug.

Interoperability & Coding

Concept ID (RxCUI)
1437703
RxNorm Unique Identifier for the standardized concept.
Atom ID (RXAUI)
12303353
Unique identifier for this specific name variation (Atom).
Term Type (TTY)
SBDC
Semantic Branded Drug Component (Ingredient + Strength + Brand Name)
Source Code
1437703
The "Most useful" identifier asserted by the original source vocabulary.

Source & Registry Data

Source Name
RxNorm Vocabulary (RXNORM)
The official name and abbreviation for the vocabulary source.
Source Version
20AA_260601F
The specific version of the vocabulary provided by the source.
Update Date
June 01, 2026
The date when this RxNorm data was last updated by the NLM.
License Contact
RxNorm Customer Service, , U.S. National Library of Medicine, 8600 Rockville Pike, , Bethesda, MD, United States, 20894, (888) FIND-NLM, , https://support.nlm.nih.gov/support/create-case/, https://www.nlm.nih.gov/research/umls/rxnorm/
Source licensing contact information.

Technical Attributes & Logic

RXN OBSOLETED
02/24/2025
Date the RxNorm atom became obsolete

Patient Education

Albuterol and Ipratropium Oral Inhalation


The combination of albuterol and ipratropium is used to prevent wheezing, difficulty breathing, chest tightness, and coughing in people with chronic obstructive pulmonary disease (COPD; a group of diseases that affect the lungs and airways) such as chronic bronchitis (swelling of the air passages that lead to the lungs) and emphysema (damage to the air sacs in the lungs). Albuterol and ipratropium combination is used by people whose symptoms have not been controlled by a single inhaled medication. Albuterol and ipratropium are in a class of medications called bronchodilators. Albuterol and ipratropium combination works by relaxing and opening the air passages to the lungs to make breathing easier.
[Learn More]


* Please review the disclaimer below.